Agilent Technologies (NYSE:A) Price Target Cut to $165.00 by Analysts at HSBC

Agilent Technologies (NYSE:A) had its target price cut by research analysts at HSBC from $180.00 to $165.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the medical research company’s stock. HSBC’s target price suggests a potential upside of 19.08% from the company’s previous close.

A number of other brokerages also recently weighed in on A. TD Cowen upped their target price on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a report on Thursday, May 28th. UBS Group dropped their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Barclays upped their target price on Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Robert W. Baird upped their target price on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Finally, Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their target price for the company from $150.00 to $145.00 in a report on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $161.71.

Agilent Technologies Trading Up 2.6%

NYSE A traded up $3.51 on Wednesday, hitting $138.56. 1,163,359 shares of the company were exchanged, compared to its average volume of 2,262,655. The company’s 50 day moving average price is $116.42 and its 200-day moving average price is $128.54. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The firm has a market capitalization of $39.16 billion, a P/E ratio of 27.82, a price-to-earnings-growth ratio of 2.77 and a beta of 1.26. Agilent Technologies has a twelve month low of $108.35 and a twelve month high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.84 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts predict that Agilent Technologies will post 5.99 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilent Technologies

Large investors have recently made changes to their positions in the company. Optiver Holding B.V. acquired a new position in shares of Agilent Technologies during the first quarter worth approximately $496,000. Ritter Alpha LP acquired a new position in shares of Agilent Technologies during the first quarter worth approximately $203,000. Summitry LLC lifted its holdings in shares of Agilent Technologies by 8.1% during the first quarter. Summitry LLC now owns 673,954 shares of the medical research company’s stock worth $76,817,000 after buying an additional 50,441 shares during the last quarter. Segall Bryant & Hamill LLC acquired a new position in shares of Agilent Technologies during the first quarter worth approximately $9,041,000. Finally, Essential Partners LLC lifted its holdings in shares of Agilent Technologies by 35.1% during the first quarter. Essential Partners LLC now owns 2,658 shares of the medical research company’s stock worth $303,000 after buying an additional 690 shares during the last quarter.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.